![Lotfi Yelles Chaouche](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lotfi Yelles Chaouche
Direktor/Vorstandsmitglied bei Apaxen SA
Ursprung des Netzwerks ersten Grades von Lotfi Yelles Chaouche
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Theodorus Investment Funds
![]() Theodorus Investment Funds Investment ManagersFinance Theodorus Investment Funds is a venture capital firm founded in 2003. The firm headquartered in Brussels, Belgium.
5
| Subsidiary | Investment Managers | 5 |
Apaxen SA
![]() Apaxen SA BiotechnologyHealth Technology Apaxen SA is a privately-held biotechnology company that was founded in 2018 and is based in an undisclosed location. The Belgian company has raised €5.4 million in equity and grant funding since its A round in 2019. Apaxen is focused on developing a pipeline of NLRP3 inflammasome inhibitors with a novel mechanism of action for the treatment of chronic inflammatory and autoimmune diseases. The company's clinical candidate, MFC-1040, is an orally bioavailable and selective small molecule NLRP3 inflammasome inhibitor that has demonstrated efficacy in multiple animal models of chronic inflammatory disease and pulmonary fibrosis. The company's team combines the experience required for clinical development of its products and is supported by a world-class team of scientific advisors. Apaxen has a pipeline of products at discovery and preclinical stages of development for the treatment of diseases associated with chronic inflammation that depend on NLRP3 inflammasome activation. The company was founded in 2018 by Gael Jalce, Enrico Jose Adolfo Bastianelli, and Bart Wuurman has been the CEO of the company since 2020.
4
| Holding Company | Biotechnology | 4 |
Public Company | Miscellaneous Commercial Services | 4 | |
Inhatarget Therapeutics
![]() Inhatarget Therapeutics Pharmaceuticals: MajorHealth Technology Inhatarget Therapeutics is a Belgian company that is developing targeted inhalation formulations to improve treatment for severe respiratory diseases, with a first focus on lung cancer. The company is based in Brussels, Belgium. The company is currently conducting clinical trials in 5 hospitals. The company's main objective is to create an inhaled chemotherapy for the treatment of lung cancer.
2
| Holding Company | Pharmaceuticals: Major | 2 |
NeuVasQ Biotechnologies SA
![]() NeuVasQ Biotechnologies SA Pharmaceuticals: MajorHealth Technology NeuVasQ Biotechnologies SA develops pharmaceutical products to treat neurological disorders by repairing neurovascular function. The company is based in Gosselies, Belgium. The Belgian company was founded in 2021 by Benoit Vanhollebeke.
1
| Holding Company | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Lotfi Yelles Chaouche
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Innovation Fund (BE)
![]() Innovation Fund (BE) Investment ManagersFinance Innovation Fund is a venture capital firm founded in 2015. The firm headquartered located in Schaerbeek, Belgium. | Investment Managers | Private Equity Investor Private Equity Investor | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Ghent University | College/University | Doctorate Degree Undergraduate Degree | |
Advanced Engineering Accelerator SA
![]() Advanced Engineering Accelerator SA Miscellaneous Commercial ServicesCommercial Services Advanced Engineering Accelerator SA provides business support services for engineering firms. The company is based in Charleroi, Belgium. The CEOs are Olivier Belenger, Maxime Vuckovic. The Belgian company was founded in 2018. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Ncardia SA
![]() Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Creativenture SA
![]() Creativenture SA Food DistributorsDistribution Services Creativenture SA produces and markets wines. It provides its products through Custom Wines, Gusto World and Courage Trading. The company is headquartered in Alleur, Belgium | Food Distributors | President | |
Guy Heynen Consulting | Chief Executive Officer | ||
Centre Hospitalier Universitaire de Liege | College/University | Doctorate Degree | |
Anbics AG | Chief Tech/Sci/R&D Officer | ||
Ogeda SA
![]() Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Pfizer AG | Chief Tech/Sci/R&D Officer | ||
Flanders Vaccine | Director/Board Member | ||
AnimAb BV
![]() AnimAb BV BiotechnologyHealth Technology AnimAb BV is a Belgian company that focuses on improving animal performance through its antibody-based approach that targets intestinal pathogens. AnimAb is based in Ghent, Belgium. The company helps protect piglets during their most fragile post-weaning stage. AnimAb integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies, and sustainability. The company's technology prevents intestinal bacterial colonization thanks to the direct integration with animal feed. The company's cross-disciplinary science teams developed a new antibody technology designed for oral ingestion based on a scalable, cost-effective microbial production process. The company was founded in 2020 by Eric Cox, Henri de Greve, Ann Depicker, and Nico Callewaert. Alain Wille has been the CEO of the company since 2020. | Biotechnology | General Counsel | |
Katholieke Universiteit Leuven | College/University | Graduate Degree | |
ViroVet NV
![]() ViroVet NV Pharmaceuticals: MajorHealth Technology ViroVet NV is a Belgian company that focuses on the discovery, licensing, and development of biopharmaceutical products for livestock. The company is based in Leuven, Belgium. ViroVet was founded by Erwin Blomsma, Stefaan Wera, and Nesya Goris, with Erwin Blomsma serving as the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
Vetsina Animal Diagnostics Ltd. | Chief Executive Officer | ||
Anifera Ltd. | Director/Board Member | ||
Roslin Technologies Ltd.
![]() Roslin Technologies Ltd. BiotechnologyHealth Technology Roslin Technologies Ltd. engages in the provision of agriculture biotechnology solutions. It offers genome sequencing, genotyping, gene editing, transgenics, phenotyping, and bioinformatics. The company is headquartered in Midlothian, the United Kingdom. | Biotechnology | Chief Operating Officer | |
The Open University Business School | College/University | Masters Business Admin | |
The Royal Veterinary College | College/University | Doctorate Degree | |
University of London | College/University | Doctorate Degree | |
DIM3 SA
![]() DIM3 SA Packaged SoftwareTechnology Services DIM3 SA develops decision support application software and medical devices. The firm offers Scorso, an app for the screening and follow-up of disease-related malnutrition; Nutrow, a decision support software for an optimization of clinical nutrition; and Biocorder, a connected clinical mobile assistant. The company was founded by Jean Claude Havaux on September 23, 2004 and is headquartered in Liege, Belgium. | Packaged Software | Director/Board Member | |
Adipopharma
![]() Adipopharma Miscellaneous Commercial ServicesCommercial Services Adipopharma is a French biotech company that focuses on developing treatments for insulin resistance, type 2 diabetes, and related conditions. | Miscellaneous Commercial Services | Director/Board Member | |
AbolerIS Pharma
![]() AbolerIS Pharma Pharmaceuticals: MajorHealth Technology AbolerIS Pharma develops therapeutic approaches to induce immune tolerance and preserves useful immune responses in inflammatory, autoimmune, and degenerative diseases. The company was founded by Carole Guillonneau, Ignacio Anegon and François-Xavier Hubert and is headquartered in Nantes, France. | Pharmaceuticals: Major | Director/Board Member | |
Lys Medical SRL
![]() Lys Medical SRL Miscellaneous Commercial ServicesCommercial Services Lys Medical SPRL engages in researching and developing biotechnology. The company was founded by Alain Richard Jules Delchambre, Benjamin Thomas Mertens and Jacques Maurice Devière on January 18, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Escuela Superior de Administración y Dirección de Empresas | College/University | Undergraduate Degree | |
The Louvain School of Management | College/University | Undergraduate Degree | |
Home EOS NV
![]() Home EOS NV Engineering & ConstructionIndustrial Services Home EOS NV is a company based in Farciennes, Belgium. Home EOS specializes in providing a serene and healthy living environment with effective and ecological acoustic insulation. The Belgian company was founded in 2014 and Pierre P. de Kettenis de Hollaeken has been the CEO of the company since 2016. | Engineering & Construction | Director/Board Member | |
Graftys SA
![]() Graftys SA Medical SpecialtiesHealth Technology Graftys SA designs, manufactures and markets calcium phosphate-based synthetic bone substitutes to the global orthopedic and dental surgery markets. Its research and development projects include injectable and resorbable synthetic bone substitutes, biological repair of cartilage and of the spine, as well as bone substitutes combined with pharmaceutical agents. The company was founded by Jean Marc Ferrier, Alain Valet, Jean-Michel Bouler and Aurélien Valet in September 2005 and is headquartered in Aix-en-Provence, France. | Medical Specialties | Director/Board Member | |
DoseVue NV
![]() DoseVue NV Medical SpecialtiesHealth Technology DoseVue NV is developing innovative technologies for convenient and accurate in-vivo dosimetry. It offers DoseWire Series 100 & DoseWire Series 200. The company was founded by Emiliano D Agostino in March 2013 and is headquartered in Turnhout, Belgium. | Medical Specialties | Director/Board Member | |
ESSEC Business School | College/University | Graduate Degree | |
Université Paris-Saclay | College/University | Undergraduate Degree | |
Brussels South Charleroi BioPark Dev SA | Director/Board Member | ||
ANTIGON SA
![]() ANTIGON SA Medical SpecialtiesHealth Technology Antigon SA develops, manufactures, and supplies blood safety transfusion devices. The company is based in Charleroi, Belgium. Antigon was founded in 2016 by Francis Corazza, Hanane El Kenz, and Thierry Baltus. | Medical Specialties | Director/Board Member | |
Spentys SA
![]() Spentys SA Medical SpecialtiesHealth Technology Spentys SA is a Belgian company that offers a new way of creating personalized orthopedic immobilization devices. The company is based in Brussels, Belgium. The company provides a platform for patients to request a trial and access their knowledge articles for orthopedic professionals. Spentys was founded by Maxime Pierre Fabien Pignon, Louis-Philippe F. S. Broze, and Florian Laurent Joel de Boeck, with Louis-Philippe F. S. Broze serving as the CEO since incorporation. | Medical Specialties | Director/Board Member | |
ConvEyXo SA | Director/Board Member | ||
Advanced Animal Diagnostics, Inc.
![]() Advanced Animal Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Advanced Animal Diagnostics, Inc. develops integrated systems and solutions for the detection of animal diseases. The firm engages in the researching, developing and commercializing on-farm diagnostic tests, such as QScout MLD for early detection of subclinical mastitis in dairy cows. It also provides solutions for the diagnosis and treatment of veterinary health problems including mastitis and other animal diseases. The company was founded by Rodolfo Rodriguez and Victor M. Minton in July 2001 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member | |
Tools4patient SA
![]() Tools4patient SA Packaged SoftwareTechnology Services Tools4patient SA develops and commercializes clinical development analytical tools for pharmaceutical and biotechnology companies. The company is based in Jumet, Belgium. The Belgian company was founded in 2013 by Denis Marcel Lucien Gossen, E. Iglesias Alvaro Pereira, Chantal Anne Ghislaine Cuvelier, Dominique Marcelle Renee Demolle, Jean-Marie Dethy, Chantal Christine Claudine Joelle Gossuin. Dominique Marcelle Renee Demolle has been the CEO since 2013. | Packaged Software | Director/Board Member | |
Sambrinvest SA
![]() Sambrinvest SA Investment ManagersFinance Sambrinvest SA is a venture capital firm founded in 1985. Sambrinvest SA is headquartered in Gosselies, Belgium. | Investment Managers | Private Equity Investor | |
Simmunome Ai
![]() Simmunome Ai BiotechnologyHealth Technology Simmunome, Inc. is a Canadian company founded in 2017 that uses AI to create disease models based on multi-omic data. The company is based in Montréal, Canada. The company's clinical trial simulations provide insights, allowing for go/no-go decisions and de-risking of pipelines, ultimately reducing R&D costs. | Biotechnology | Director/Board Member | |
KapCare SA
![]() KapCare SA Electronic Equipment/InstrumentsElectronic Technology KapCare SPRL develops electronic device for elders. Its product Kaspard, is an electronic device designed for elders which gives the alert in case of a bed exit, of a fall or of not returning to bed within a certain time. The company was founded by Karin Kaspar and Philippe Albert Kaplan on September 13, 2017 and is headquartered in Oudergem, Belgium. | Electronic Equipment/Instruments | Director/Board Member | |
E-Health Venture NV
![]() E-Health Venture NV Information Technology ServicesTechnology Services E-Health Venture NV is an incubator and studio for startups and scale-ups in e-health. The company is based in Anderlecht, Belgium. The Belgian company's network provides start-ups with critical access to customers, funding, strategic coaching, and operational support. The company was founded in 2018 and empowers forward-looking individuals and organizations in healthcare by nurturing innovation within an ecosystem of partners with a range of expertise. | Information Technology Services | Director/Board Member |
Statistik
International
Belgien | 31 |
Frankreich | 7 |
Vereinigtes Königreich | 7 |
Schweiz | 4 |
Vereinigte Staaten | 3 |
Sektoral
Health Technology | 19 |
Consumer Services | 11 |
Commercial Services | 6 |
Technology Services | 4 |
Finance | 3 |
Operativ
Director/Board Member | 55 |
Chief Executive Officer | 21 |
Chief Tech/Sci/R&D Officer | 15 |
Corporate Officer/Principal | 14 |
Private Equity Investor | 8 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Lotfi Yelles Chaouche
- Unternehmensverbindungen